What Researchers Did
Researchers randomly assigned 68 herpes zoster patients to either a control group receiving drug therapy or a hyperbaric oxygen (HBO2) group receiving both drugs and HBO2.
What They Found
The HBO2 group showed a significantly higher therapeutic efficacy of 97.22% compared to 81.25% in the control group (p < 0.05). Patients receiving HBO2 also experienced significantly lower rates of post-herpetic neuralgia, faster scar formation, and reduced pain and depression scores (p < 0.05).
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The relatively small sample size of 68 patients may limit the generalizability of these findings.